Market Share of North America Human Insulin Drugs Industry
The North American human insulin market is highly fragmented, with three major manufacturers having a large market share. In the United States, there are no other players except Novo Nordisk, Sanofi, and Eli Lilly. In the remaining countries, the manufacturers confine themselves to other local or region-specific manufacturers. Mergers and acquisitions that happened between the players in the recent past helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance to develop and commercialize Basaglar (insulin glargine).
North America Insulin Market Leaders
-
Sanofi S.A.
-
Novo Nordisk A/S
-
Eli Lilly and Company
-
Pfizer Inc
-
Biocon Limited
*Disclaimer: Major Players sorted in no particular order
